Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $1.8 million.

  • Prokidney's Other Accumulated Expenses fell 3196.19% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 3196.19%. This contributed to the annual value of $1.9 million for FY2024, which is 2441.41% up from last year.
  • According to the latest figures from Q3 2025, Prokidney's Other Accumulated Expenses is $1.8 million, which was down 3196.19% from $1.2 million recorded in Q2 2025.
  • Prokidney's 5-year Other Accumulated Expenses high stood at $2.6 million for Q3 2024, and its period low was $21000.0 during Q4 2022.
  • Over the past 4 years, Prokidney's median Other Accumulated Expenses value was $1.5 million (recorded in 2023), while the average stood at $1.3 million.
  • As far as peak fluctuations go, Prokidney's Other Accumulated Expenses soared by 721428.57% in 2023, and later tumbled by 4404.82% in 2025.
  • Quarter analysis of 4 years shows Prokidney's Other Accumulated Expenses stood at $21000.0 in 2022, then soared by 7214.29% to $1.5 million in 2023, then grew by 24.41% to $1.9 million in 2024, then decreased by 6.54% to $1.8 million in 2025.
  • Its Other Accumulated Expenses was $1.8 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.6 million in Q1 2025.